Search

Search Constraints

You searched for: Author/Creator Keystone, Edward C

Search Results

21. Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trial. (September 2019)

23. P210 Efficacy and safety of filgotinib for patients with RA with inadequate response to methotrexate: FINCH1 primary outcome results. (20th April 2020)

24. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. Issue 11 (10th August 2017)

26. Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate. Issue 2 (27th November 2014)

28. The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis. Issue 6 (15th May 2015)

29. Treating rheumatoid arthritis to target: recommendations of an international task force. Issue 4 (9th March 2010)